Efficacy of buffered and enteric-coated acetylsalicylic acid on platelet aggregation in patients with stable coronary artery disease and type 2 diabetes (CASCADE): rationale and design of a single-center observational comparative study

Aim. Enteric-coated acetylsalicylic acid (ASA) is released more slowly and is absorbed in smaller quantities and over a longer period of time, which may lead to bioavailability and antiplatelet effect decrease compared to conventional ASA. Patients with diabetes are characterized by increased platel...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Zh. D. Kobalava, A. S. Pisaryuk, A. A. Filkova, E. S. Tukhsanboev, A. N. Amirova, A. D. Korneichuk, G. S. Pavlikov, L. R. Burkhanova, I. A. Meray, M. A. Panteleev, A. N. Sveshnikova
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	«FIRMA «SILICEA» LLC 2025-02-01
Saila:	Российский кардиологический журнал
Gaiak:	diabetes stable coronary artery disease platelet aggregation acetylsalicylic acid resistance
Sarrera elektronikoa:	https://russjcardiol.elpub.ru/jour/article/view/6250
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!